Affiliation: Genetic Health Services Victoria
- Monoclonal antibodies as therapeutic agents for cancerMarion Harris
Murdoch Children s Research Institute, Royal Children s Hospital, Parkville, Victoria, Australia
Lancet Oncol 5:292-302. 2004..Positive results for other antibodies in various stages of clinical development provide hope that anticancer antibodies will have an effect on clinical oncology practice in the next 10 years...
- Controversies and ethical issues in cancer-genetics clinicsMarion Harris
Genetic Health Services Victoria, Murdoch Children s Research Institute, Royal Children s Hospital, Parkville, Victoria 3050, Australia
Lancet Oncol 6:301-10. 2005....
- Optimal selection of individuals for BRCA mutation testing: a comparison of available methodsPaul A James
Familial Cancer Centre, Murdoch Children s Research Institute, Melbourne, Australia
J Clin Oncol 24:707-15. 2006..We examined the performance of six different methods with the aim of identifying an optimal strategy for selecting individuals for mutation testing in clinical practice...
- Re: Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instabilityFinlay Macrae
J Natl Cancer Inst 97:936-7; author reply 937-8. 2005